Catalyst Wire Dossier Catalyst Wire Dossier

Venclexto

Venetoclax · AbbVie/Genentech (Roche)
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Venclexto, covering 2026-02-24 to 2026-02-24. Get the full timeline:

Most recent: Clinical Trial Update: Early Clonal Dynamics During Venetoclax Treatment for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) [Phase 2]

See pricing